ArticleGene therapy2026

SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.

Lena Dorsheimer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.